BACKGROUND: Avascular necrosis (AVN) of the femoral head is a disease that usually affects patients
in the 20-50 year age group of life. The disease progresses with time and if left untreated, it may leads to
complete deterioration of the hip joint. Various treatments modalities are available as non-surgical, core decompression alone
or with autologous bone graft or PRP or bone marrow aspirate or vascularised bular graft, osteotomies and hip replacement.
We planned to evaluate the efcacy of core decompression and autologous bone grafting in the management of AVN of the
hip.
MATERIALS AND METHODS- We performed a prospective study with 20 patients of 20-50 years age group having cat-arlet
stage 1 [8 patients ] and 2a [12 patients]. The study period was from January 2018 to December 2019. All patients were treated
with core decompression and autologous cancellous bone grafting. Pre-operative Harris hip score [HHS], plain radiograph
and MRI were compared with postoperative ones at different time intervals.
RESULTS- Average Follow Up Period Was 12 Months And Average Age Group Of Presentation Was 31.1 Years . Males Were
More Affected And Most Common Causes Were Idiopathic And Steroid Use. Average Preoperative Hhs Was 56.20 And
Postoperative Hhs Was 80.15. At The End Of 1 Year, 12 Patients Showed Remission, 6 Patients Showed Preoperative Stage While
2 Patients Progressed To Advanced Stage And Required Arthroplasty.
CONCLUSION-core Decompression And Autologous Bone Grafting Is Effective Treatment Modality In Early Avascular Necrosis
Of Femur Head In Terms Of Radiological And Clinical Results And Delaying Arthroplasty
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.